Astrana Health, Inc. (NASDAQ:ASTH) Receives $65.17 Average Price Target from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been given a consensus rating of “Moderate Buy” by the nine analysts that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $63.67.

ASTH has been the topic of a number of research analyst reports. KeyCorp assumed coverage on shares of Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Truist Financial dropped their price objective on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. BTIG Research increased their price target on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Finally, Robert W. Baird lifted their price objective on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th.

Hedge Funds Weigh In On Astrana Health

A number of large investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC purchased a new position in shares of Astrana Health in the 3rd quarter worth approximately $34,000. Nisa Investment Advisors LLC purchased a new position in Astrana Health in the third quarter worth $35,000. KBC Group NV acquired a new position in shares of Astrana Health during the third quarter worth $70,000. Quarry LP purchased a new stake in shares of Astrana Health during the 3rd quarter valued at $77,000. Finally, Quest Partners LLC acquired a new stake in shares of Astrana Health in the 3rd quarter worth $133,000. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Price Performance

Shares of ASTH stock opened at $31.34 on Friday. The stock has a 50 day moving average price of $38.01 and a 200 day moving average price of $46.80. Astrana Health has a 52-week low of $29.08 and a 52-week high of $63.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The firm has a market capitalization of $1.76 billion, a P/E ratio of 24.11, a P/E/G ratio of 1.80 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting the consensus estimate of $0.33. The business had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period last year, the company earned $0.47 earnings per share. As a group, sell-side analysts predict that Astrana Health will post 1.16 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.